Melanoma Clinical Trial

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

Summary

The goal of this study is to observe metabolic features associated with human melanoma tumors.

View Full Description

Full Description

This is a single center, correlative study designed to assess metabolic features of melanoma tumors in patients. The study will involve the collection of melanoma tissue at the time of surgical biopsy or excision. All samples will be assessed by mass spectrometry for metabolomic analysis. A subset of patients will have received [U-13C]glucose infusions which will be utilized for isotope tracing metabolic analysis. Relevant clinical data (eg survival, metastasis) will be correlated with metabolic findings.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with known or probable malignant melanoma lesions requiring surgical biopsy or excision.
Subjects of all races and ethnic origins over age 18.

Exclusion Criteria:

Not a surgical candidate
Poorly controlled diabetes

Study is for people with:

Melanoma

Estimated Enrollment:

400

Study ID:

NCT06400550

Recruitment Status:

Recruiting

Sponsor:

University of Texas Southwestern Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Texas Southwestern Medical Center
Dallas Texas, 75390, United States More Info
Aleuna Lee
Contact
214-645-8968
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

400

Study ID:

NCT06400550

Recruitment Status:

Recruiting

Sponsor:


University of Texas Southwestern Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.